Related Experiment Videos
Drug insight: Statin use in the elderly
O Christopher Raffel1, Harvey D White
1Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Nature Clinical Practice. Cardiovascular Medicine
|May 27, 2006
Summary
Statins are effective for preventing secondary cardiovascular events. This review examines their proven benefits in elderly patients following acute coronary syndromes, addressing underuse concerns.
Area of Science:
- Cardiology
- Geriatric Medicine
- Pharmacology
Background:
- Elderly patients have higher adverse outcomes post-myocardial infarction (MI) or acute coronary syndromes (ACS).
- Effective therapies are crucial for this demographic, offering significant gains from evidence-based treatments.
- Established efficacy of statins in secondary cardiovascular disease prevention, with early initiation showing added benefit.
Purpose of the Study:
- To review the evidence for statin effectiveness in elderly patients with acute coronary syndromes.
- To address the underuse of statins in this population due to uncertainties regarding efficacy.
Main Methods:
- Literature review evaluating clinical trial data and observational studies.
- Analysis of evidence specifically pertaining to the elderly subgroup.
Main Results:
- Statins are firmly established as effective for secondary cardiovascular prevention.
- Early statin therapy post-ACS provides additional benefits.
- Evidence supports statin use in the elderly, despite historical underprescription.
Conclusions:
- Statins are beneficial for secondary prevention in elderly patients after ACS.
- Addressing uncertainties can improve statin utilization in this growing patient group.
- Evidence supports the established efficacy of statins in older adults.